Ares Capital Co. (NASDAQ:ARCC) has been assigned an average recommendation of “Buy” from the fourteen analysts that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and nine have given a buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $16.13.

A number of equities analysts have recently issued reports on ARCC shares. BidaskClub raised Ares Capital from a “sell” rating to a “hold” rating in a research report on Wednesday, October 28th. Janney Montgomery Scott raised Ares Capital from a “neutral” rating to a “buy” rating in a research report on Tuesday, October 27th. Raymond James upped their target price on Ares Capital from $16.00 to $17.50 and gave the company an “outperform” rating in a research report on Friday, January 8th. Barclays downgraded Ares Capital from an “overweight” rating to an “equal weight” rating and upped their target price for the company from $16.00 to $17.00 in a research report on Thursday, December 10th. Finally, JPMorgan Chase & Co. downgraded Ares Capital from an “overweight” rating to a “neutral” rating in a research report on Thursday, December 10th.

In other news, VP Joshua M. Bloomstein bought 2,000 shares of the stock in a transaction dated Wednesday, October 28th. The shares were acquired at an average cost of $13.82 per share, with a total value of $27,640.00. Following the purchase, the vice president now directly owns 13,500 shares in the company, valued at approximately $186,570. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO R. Kipp Deveer bought 75,000 shares of the stock in a transaction dated Wednesday, October 28th. The shares were purchased at an average cost of $13.98 per share, for a total transaction of $1,048,500.00. Following the completion of the purchase, the chief executive officer now owns 300,000 shares in the company, valued at $4,194,000. The disclosure for this purchase can be found here. Insiders have acquired a total of 90,000 shares of company stock worth $1,256,590 over the last ninety days. 0.60% of the stock is owned by insiders.

Several hedge funds have recently bought and sold shares of ARCC. Gilbert & Cook Inc. increased its stake in Ares Capital by 4.6% during the 3rd quarter. Gilbert & Cook Inc. now owns 724,857 shares of the investment management company’s stock worth $10,114,000 after purchasing an additional 31,808 shares in the last quarter. Cetera Advisors LLC lifted its stake in Ares Capital by 16.0% in the 3rd quarter. Cetera Advisors LLC now owns 137,458 shares of the investment management company’s stock worth $1,918,000 after purchasing an additional 18,983 shares in the last quarter. Global Retirement Partners LLC lifted its stake in Ares Capital by 24.4% in the 3rd quarter. Global Retirement Partners LLC now owns 3,940 shares of the investment management company’s stock worth $55,000 after purchasing an additional 773 shares in the last quarter. Raymond James Trust N.A. lifted its stake in Ares Capital by 26.1% in the 3rd quarter. Raymond James Trust N.A. now owns 14,584 shares of the investment management company’s stock worth $203,000 after purchasing an additional 3,017 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC lifted its stake in Ares Capital by 37.3% in the 3rd quarter. Schonfeld Strategic Advisors LLC now owns 139,381 shares of the investment management company’s stock worth $1,944,000 after purchasing an additional 37,881 shares in the last quarter. 31.33% of the stock is currently owned by institutional investors and hedge funds.

Ares Capital stock traded up $0.01 during mid-day trading on Wednesday, reaching $16.94. 1,641,413 shares of the company were exchanged, compared to its average volume of 1,685,369. The business has a fifty day moving average of $16.79 and a 200 day moving average of $14.98. The company has a debt-to-equity ratio of 1.08, a quick ratio of 1.25 and a current ratio of 1.25. The firm has a market cap of $7.16 billion, a P/E ratio of 22.57 and a beta of 1.20. Ares Capital has a 12-month low of $7.90 and a 12-month high of $19.33.

Ares Capital (NASDAQ:ARCC) last issued its quarterly earnings results on Sunday, November 1st. The investment management company reported $0.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.01. The business had revenue of $352.00 million for the quarter, compared to the consensus estimate of $343.90 million. Ares Capital had a return on equity of 10.05% and a net margin of 21.28%. The business’s quarterly revenue was down 9.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.48 earnings per share. Sell-side analysts predict that Ares Capital will post 1.59 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, December 30th. Shareholders of record on Tuesday, December 15th were given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 9.45%. The ex-dividend date was Monday, December 14th. Ares Capital’s dividend payout ratio is currently 84.66%.

Ares Capital Company Profile

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors.

Recommended Story: How to Calculate Compound Annual Growth Rate (CAGR)

Analyst Recommendations for Ares Capital (NASDAQ:ARCC)

Receive News & Ratings for Ares Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ares Capital and related companies with MarketBeat.com's FREE daily email newsletter.